Clinical Trials Browser

Completed × Hematologic Neoplasms × benralizumab × Clear all

NCT04552288 2026-06-01

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Phase 2 Completed

51 enrolled 8 charts

Other hematologic neoplasm

Hematologic Neoplasms